Ma Zhi-Mei, Lai Shang-Lei, Zhu Jin-Yan, Ding Qin-Chao, Dou Xiao-Bing, Li Song-Tao
School of Life Sciences, Zhejiang Chinese Medical University Hangzhou 310053, China.
School of Public Health, Zhejiang Chinese Medical University Hangzhou 310053, China.
Zhongguo Zhong Yao Za Zhi. 2022 Feb;47(4):1017-1023. doi: 10.19540/j.cnki.cjcmm.20211008.701.
This study explored the protective effect of atractylenolide Ⅰ(AO-Ⅰ) against acetaminophen(APAP)-induced acute liver injury(ALI) in mice and its underlying mechanism. C57 BL/6 J mice were randomly divided into a control group, an APAP group(500 mg·kg(-1)), a low-dose combination group(500 mg·kg(-1) APAP + 60 mg·kg(-1) AO-Ⅰ), and a high-dose combination group(500 mg·kg(-1) APAP + 120 mg·kg(-1) AO-Ⅰ). ALI was induced by intraperitoneal injection of APAP(500 mg·kg(-1)). AO-Ⅰ by intragastric administration was performed 2 hours before APAP treatment, and the control group received the same dose of solvent by intragastric administration or intraperitoneal injection. The protective effect of AO-Ⅰ against APAP-induced ALI was evaluated by detecting alanine aminotransferase(ALT) and aspartate aminotransferase(AST) levels in the plasma and H&E staining in liver tissues of mice. The malondialdehyde(MDA) and glutathione(GSH) content and catalase(CAT) activity in mouse liver tissues were detected to evaluate the effect of AO-Ⅰ on APAP-induced oxidative stress in the liver. The proteins in the liver p38 mitogen-activated protein kinase(p38 MAPK), c-jun N-terminal kinase(JNK), and nuclear factor kappa-B p65(NF-κB p65) signaling pathways were measured by Western blot, and the liver inflammatory cytokines interleukin-1β(IL-1β) and interleukin-6(IL-6) were detected by real-time PCR. Compared with the APAP group, the combination groups showed reduced APAP-induced ALT level and liver MDA content, potentiated liver CAT activity, and elevated GSH content. Mechanistically, AO-Ⅰ treatment significantly inhibited APAP-up-regulated MAPK phosphorylation and NF-κB p65, and significantly reduced the transcriptional activities of IL-1β and IL-6, downstream targets of NF-κB p65. AO-Ⅰ can improve APAP-induced ALI and the underlying mechanism is related to the inhibition of the MAPK/NF-κB p65 signaling pathway in APAP-challenged mice.
本研究探讨了白术内酯Ⅰ(AO-Ⅰ)对乙酰氨基酚(APAP)诱导的小鼠急性肝损伤(ALI)的保护作用及其潜在机制。将C57 BL/6 J小鼠随机分为对照组、APAP组(500 mg·kg⁻¹)、低剂量联合组(500 mg·kg⁻¹ APAP + 60 mg·kg⁻¹ AO-Ⅰ)和高剂量联合组(500 mg·kg⁻¹ APAP + 120 mg·kg⁻¹ AO-Ⅰ)。通过腹腔注射APAP(500 mg·kg⁻¹)诱导ALI。在APAP处理前2小时通过灌胃给予AO-Ⅰ,对照组通过灌胃或腹腔注射给予相同剂量的溶剂。通过检测小鼠血浆中的丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)水平以及肝组织的苏木精-伊红(H&E)染色来评估AO-Ⅰ对APAP诱导的ALI的保护作用。检测小鼠肝组织中的丙二醛(MDA)和谷胱甘肽(GSH)含量以及过氧化氢酶(CAT)活性,以评估AO-Ⅰ对APAP诱导的肝脏氧化应激的影响。通过蛋白质免疫印迹法检测肝脏p38丝裂原活化蛋白激酶(p38 MAPK)、c-jun氨基末端激酶(JNK)和核因子κB p65(NF-κB p65)信号通路中的蛋白质,通过实时聚合酶链反应检测肝脏炎性细胞因子白细胞介素-1β(IL-1β)和白细胞介素-6(IL-6)。与APAP组相比,联合组显示APAP诱导的ALT水平和肝脏MDA含量降低,肝脏CAT活性增强以及GSH含量升高。机制上,AO-Ⅰ处理显著抑制了APAP上调的MAPK磷酸化和NF-κB p65,并显著降低了NF-κB p65下游靶点IL-1β和IL-6的转录活性。AO-Ⅰ可以改善APAP诱导的ALI,其潜在机制与抑制APAP攻击小鼠中的MAPK/NF-κB p65信号通路有关。